5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.84▼ | 5.84▼ | 5.84▼ | 6.05▼ | 5.87▼ |
MA10 | 5.86▼ | 5.84▼ | 5.87▼ | 6.17▼ | 4.94▲ |
MA20 | 5.87▼ | 5.93▼ | 6.06▼ | 6.13▼ | 4.26▲ |
MA50 | 6.12▼ | 6.19▼ | 6.22▼ | 4.92▲ | 4.32▲ |
MA100 | 6.24▼ | 6.22▼ | 6.19▼ | 4.23▲ | 5.79▲ |
MA200 | 6.24▼ | 5.84▼ | 5.22▲ | 4.21▲ | 22.53▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | -0.002▼ | -0.022▼ | -0.129▼ | 0.306▲ |
RSI | 37.069▼ | 36.113▼ | 35.692▼ | 50.826▲ | 60.854▲ |
STOCH | 51.381 | 34.873 | 19.167▼ | 40.877 | 80.284▲ |
WILL %R | -73.529 | -85.000▼ | -89.286▼ | -87.678▼ | -33.896 |
CCI | -113.375▼ | -98.918 | -93.929 | -159.033▼ | 90.754 |
MA | $CLNN Price Crossed Below MA(26) | Set Alert |
Thursday, September 25, 2025 05:10 AM
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active progressive MS (primary progressive and ...
|
Tuesday, September 16, 2025 09:21 PM
Clene Inc. reported new preclinical data on its drug candidate CNM-Au8 for Parkinson's disease. The therapy improved mitochondrial ...
|
Tuesday, September 02, 2025 01:00 AM
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/09/25 | 5.88 | 5.90 | 5.75 | 5.795 | 55,773 |
25/09/25 | 6.14 | 6.14 | 5.665 | 5.875 | 81,244 |
24/09/25 | 6.21 | 6.2886 | 5.90 | 6.05 | 94,850 |
23/09/25 | 6.45 | 6.4977 | 6.03 | 6.12 | 50,075 |
22/09/25 | 6.42 | 6.49 | 6.27 | 6.40 | 79,181 |
19/09/25 | 6.36 | 6.41 | 6.1765 | 6.39 | 53,831 |
18/09/25 | 6.17 | 6.5169 | 6.17 | 6.32 | 48,751 |
17/09/25 | 6.31 | 6.5383 | 6.14 | 6.17 | 113,164 |
16/09/25 | 6.15 | 6.54 | 6.01 | 6.33 | 60,466 |
15/09/25 | 5.94 | 6.27 | 5.8601 | 6.25 | 48,337 |
|
|
||||
|
|
||||
|
|